| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer
1 company
Alexander Azoy is Chief Accounting Officer at RCUS. Alexander Azoy's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $748K at current prices.
Our model assigns Alexander Azoy a middling insider score of 51/100, based on 11 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -30.7%.
The RCUS filings lean toward selling, a net 23,389 shares.
Alexander Azoy has 17 Form 4 filings on record from July 2023 to August 2026, all as Chief Accounting Officer at Arcus Biosciences (RCUS), 2023–2026.
The 25 reported transactions were 12 open-market sales, 4 dispositions back to the company, 3 stock awards and 3 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 10 sales worth about $500K.
The largest open-market sale was 8,832 shares of RCUS at an average $22.13 on December 18, 2025, about $195K.
All 10 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sale+OE10b5-1 | 2,827 | $30.00 | $84,810.00 | -6.7% | - | - | |
| Jun 1, 2026 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 2,562 | $25.77 | $66,023.76 | -6.1% | +14.1% | - | |
| Dec 18, 2025 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 8,832 | $22.13 | $195,433.63 | -32.3% | +1.0% | - | |
| Nov 26, 2025 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sale+OE10b5-1 | 1,900 | $26.00 | $49,400.00 | -6.5% | -21.0% | - | |
| Sep 29, 2025 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 2,831 | $13.00 | $36,803.00 | -9.4% | +75.2% | +92.6% | |
| Sep 5, 2025 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 1,579 | $11.88 | $18,758.05 | -5.0% | +107.2% | +143.3% | |
| Dec 2, 2024 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 201 | $15.32 | $3,079.32 | -1.0% | -34.1% | +59.5% | |
| Aug 13, 2024 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 1,357 | $14.97 | $20,314.29 | -6.6% | +13.5% | -35.7% | |
| Dec 1, 2023 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 282 | $14.95 | $4,215.90 | -2.4% | +19.0% | -3.9% | |
| Jul 3, 2023 | RCUS Arcus Biosciences, Inc. | Chief Accounting Officer | Sell10b5-1 | 1,018 | $20.41 | $20,777.38 | -8.1% | -15.4% | -28.3% |